Cargando…

A Randomized, Controlled, Trial of Short Cycle Intermittent Compared to Continuous Antiretroviral Therapy for the Treatment of HIV Infection in Uganda

BACKGROUND: Short cycle treatment interruption could reduce toxicity and drug costs and contribute to further expansion of antiretroviral therapy (ART) programs. METHODS: A 72 week, non-inferiority trial enrolled one hundred forty six HIV positive persons receiving ART (CD4+ cell count ≥125 cells/mm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reynolds, Steven J., Kityo, Cissy, Hallahan, Claire W., Kabuye, Geoffrey, Atwiine, Diana, Mbamanya, Frank, Ssali, Francis, Dewar, Robin, Daucher, Marybeth, Davey, Richard T., Mugyenyi, Peter, Fauci, Anthony S., Quinn, Thomas C., Dybul, Mark R.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860845/ https://www.ncbi.nlm.nih.gov/pubmed/20442758 http://dx.doi.org/10.1371/journal.pone.0010307

Ejemplares similares

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe
por: Walker, A. Sarah, et al.
Publicado: (2012)

Identification of gaps for implementation science in the HIV prevention, care and treatment cascade; a qualitative study in 19 districts in Uganda
por: Bajunirwe, Francis, et al.
Publicado: (2016)

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
por: Medina Lara, Antonieta, et al.
Publicado: (2012)

Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study
por: Bajunirwe, Francis, et al.
Publicado: (2019)

HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda
por: Kityo, Cissy, et al.
Publicado: (2016)

Clinical Differences between Younger and Older Adults with HIV/AIDS Starting Antiretroviral Therapy in Uganda and Zimbabwe: A Secondary Analysis of the DART Trial
por: Parikh, Sujal M., et al.
Publicado: (2013)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2016)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2017)

The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda
por: Kigozi, Brian K, et al.
Publicado: (2009)

Validation of World Health Organisation HIV/AIDS Clinical Staging in Predicting Initiation of Antiretroviral Therapy and Clinical Predictors of Low CD4 Cell Count in Uganda
por: Baveewo, Steven, et al.
Publicado: (2011)

Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services—A Qualitative Study in 19 Ugandan Districts
por: Bajunirwe, Francis, et al.
Publicado: (2018)

Determinants of Clinician Knowledge on Aging and HIV/AIDS: A Survey of Practitioners and Policy Makers in Kampala District, Uganda
por: Obuku, Ekwaro A., et al.
Publicado: (2013)

Circulating plasma NT-proBNP predicts subclinical coronary atherosclerosis on CT angiography among older adults in Uganda
por: Shakil, Saate S, et al.
Publicado: (2023)

Social capital and resilience among people living on antiretroviral therapy in resource-poor Uganda
por: Nanfuka, Esther Kalule, et al.
Publicado: (2018)

High Level of Viral Suppression and Low Switch Rate to Second-Line Antiretroviral Therapy among HIV-Infected Adult Patients Followed over Five Years: Retrospective Analysis of the DART Trial
por: Kityo, Cissy, et al.
Publicado: (2014)

Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
por: Musana, Hellen, et al.
Publicado: (2021)

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
por: Nanzigu, Sarah, et al.
Publicado: (2013)

Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study
por: Boender, T. Sonia, et al.
Publicado: (2012)

Sex-specific performance of the ASCVD pooled cohort equation risk calculator as a correlate of coronary artery calcium in Kampala, Uganda
por: Kentoffio, Katherine, et al.
Publicado: (2022)

Coronary artery calcium, HIV and inflammation in Uganda compared with the USA
por: Alencherry, Ben, et al.
Publicado: (2019)

Paying to Normalize Life: Monetary and Psychosocial Costs of Realizing a Normal Life in the Context of Free Antiretroviral Therapy Services in Uganda
por: Nanfuka, Esther Kalule, et al.
Publicado: (2019)

Sex, HIV Status, and Measures of Cardiac Stress and Fibrosis in Uganda
por: Kipke, Jasmine, et al.
Publicado: (2021)

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial
por: Paton, Nicholas I, et al.
Publicado: (2017)

Early mortality following ART initiation in HIV-infected adults and children in Uganda and Zimbabwe
por: Walker, AS, et al.
Publicado: (2010)

MicroRNA Expression Profiling in HCV-Infected Human Hepatoma Cells Identifies Potential Anti-Viral Targets Induced by Interferon-α
por: Zhang, Xiaozhen, et al.
Publicado: (2013)

Gaps in vaccine management practices during vaccination outreach sessions in rural settings in southwestern Uganda
por: Flavia, Atwiine, et al.
Publicado: (2023)

CD25(+)CD4(+) Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4(+) and CD8(+) HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status
por: Kinter, Audrey L., et al.
Publicado: (2004)

Diminishing Availability of Publicly Funded Slots for Antiretroviral Initiation among HIV-Infected ART-Eligible Patients in Uganda
por: Geng, Elvin H., et al.
Publicado: (2010)

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy
por: Crabtree-Ramirez, Brenda, et al.
Publicado: (2022)

Predictors of breastfeeding self‐efficacy among women attending an urban postnatal clinic, Uganda
por: Nankumbi, Joyce, et al.
Publicado: (2019)

Temporal trends of early mortality and its risk factors in HIV-infected adults initiating antiretroviral therapy in Uganda
por: Ssempijja, Victor, et al.
Publicado: (2020)

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
por: Reynolds, Steven J, et al.
Publicado: (2012)

A Sex-Stratified Analysis of Monocyte Phenotypes Associated with HIV Infection in Uganda
por: Huaman, Moises A., et al.
Publicado: (2021)

Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study
por: Okoboi, Stephen, et al.
Publicado: (2016)

A Human-Centered Approach to CV Care: Infrastructure Development in Uganda
por: Longenecker, Christopher T., et al.
Publicado: (2018)

Molecular Characterization of Salmonella from Human and Animal Origins in Uganda
por: Kagirita, Atek Atwiine, et al.
Publicado: (2017)

Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda
por: Billioux, Alexander, et al.
Publicado: (2015)

Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
por: Kirenga, Bruce, et al.
Publicado: (2021)

First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda
por: Poon, Art F. Y., et al.
Publicado: (2019)

Sex modifies the association between HIV and coronary artery disease among older adults in Uganda
por: Longenecker, Chris T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gqarhbcc0d16ibt10ftsdasbi9